Biopharmaceutical Fermentation Market: By Product Type (Upstream Process and Downstream Process) ,By Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, and Others), By End User (Biopharmaceutical Industries, Contract Research Organization, Food Industries, Academic Research Institutes, and Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Biopharmaceutical Fermentation Market size was valued at USD 9,840.2 million in 2023 and poised to grow at a Significant CAGR of 4.8% from 2024-2030. The technique of incubation microbes in a contained tank or fermenter under controlled settings of aeration, agitation, temperature, and pH is known as a biopharmaceutical fermentation system. Fermentation is the only method for making chemical APIs that rely entirely on microbes like antibiotics or secondary metabolites produced by fungi that act as anti-infectious or anti-cancer drugs or lipid A produced by gram-negative bacteria that act as adjuvants. Such organic molecules can be created from their building blocks using a multi-step synthesis process which would be highly time-consuming and costly if produced in the lab while maintaining the chiral and stereospecific characteristics.

The COVID-19 epidemic hurt the biopharmaceutical fermentation market's growth in its early stages, but this market is anticipated to acquire momentum because of the pressing need to create a vaccine and other biological products. Numerous significant developments were produced in the field of pharmaceutical R&D as a result of COVID-19. To safeguard people worldwide from this virus, scientists and researchers are attempting to uncover diagnostics, therapies, and novel vaccinations. The biopharmaceutical fermentation systems market has grown as a result of these developments. For example, the Journal of Industrial Integration and Management reports that in 2021, due to recent advancements in the R&D field and technological solutions based on biosensors, these biosensors will be used to monitor the real-time activity of bioreactors for the determination of various physiological and pharmacological parameters as well as to supervise synthetic specifications in the manufacturing operation (in bioreactors). One of the principal elements propelling the development of the biopharmaceutical fermentation systems market is the rising need for biotechnology-based advanced products, such as monoclonal antibodies and antibody derivatives, vaccines, and monoclonal antibodies, as well as rising research and development to generate biomedical substances.

Key Developments in the Biopharmaceutical Fermentation Market:
  • In February 2021, the commercial production, formulation, and downstream processing of CureVac's CVnCoV COVID-19 candidate vaccine was disclosed by Rentschler Biopharma, a contract development and manufacturing organization (CDMO) with headquarters in Germany. In a similar vein, Bayer also declared that it would produce 160 million doses of CVnCoV in 2022.
  • In December 2020, Thermo Fischer Scientific started to grow in North America and other regions to produce several essential drugs, vaccines, and treatments for commercial sale. 15 (commercial Good Manufacturing Practices) cGMP supporting a variety of manufacturing capabilities were added as a result of this growth.  

Biopharmaceutical Fermentation Market Summary

Study Period

2024 - 2030

Base Year

2023

CAGR

4.8%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Biopharmaceutical Fermentation Market Dynamics

The aging of the population, the rise in the prevalence of chronic diseases worldwide, and the rising need for human services all contribute to the interest in biopharmaceuticals. This is most likely the reason to foster the growth of the global market for biopharmaceutical fermentation systems over the anticipated term. A few pharmaceutical companies are working on novel ideas for new schemes and natural remedies to address unmet medical needs. The market for biopharmaceutical fermentation is also being driven by these technological developments in bioproduction, the widespread use of downstream processing in biotechnological products, and genetically altered microbial strains. For instance, the creation of novel biological medications for the treatment of uncommon and autoimmune disorders and viral infections was announced in the journal Biomedicine in 2021, sparking a surge in biopharmaceutical R&D. Research-based biopharmaceutical firms are dedicated to improving knowledge and creating cutting-edge drugs, which overall will propel the biopharmaceutical fermentation system market growth in the foretell period. Because older people are more likely to develop chronic diseases, there is a rising need for biologics, driving the market. Therefore, as chronic illnesses become more prevalent worldwide, there is a rising necessity for biologics, and their manufacturing is steadily growing. Since biologics are primarily manufactured in these biopharmaceutical sectors, boosting the manufacturing of biotech-based goods is anticipated to support the growth of the biopharmaceutical fermentation system market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Biopharmaceutical Fermentation Market Segmentation

By Product Type
  • Upstream Process
    • Bioreactors/Fermenters
    • Bioprocess Analyzers
    • Process Monitoring System
    • Culture & Media Preparation
    • Other Upstream Products
  • Downstream Process
    • Filtration and Separation
    • Chromatography
    • Consumables and Accessories
    • Other Downstream Products
By Application
  • Antibiotics
  • Recombinant Proteins
  • Monoclonal Antibodies
  • Probiotics
  • Other Applications
By End User
  • Biopharmaceutical Industries
  • Contract Research Organization
  • Food Industries
  • Academic Research Institutes
  • Others

Frequently Asked Questions

The biopharmaceutical fermentation market size was valued at USD 9,840.2 million in 2023

GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius Stedim Biotech, Merck KGaA, Eppendorf AG, Hoffmann-La Roche Ltd.

North America is the fastest-growing region for the biopharmaceutical fermentation market

1. Executive Summary
2. Global Biopharmaceutical Fermentation Market Introduction
2.1. Global Biopharmaceutical Fermentation Market Taxonomy
2.2. Global Biopharmaceutical Fermentation Market Definitions
2.2.1. By Product Type
2.2.2. By Application
2.2.3. By End User
2.2.4. By Region
3. Global Biopharmaceutical Fermentation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biopharmaceutical Fermentation Market Dynamic Factors - Impact Analysis
3.6. Global Biopharmaceutical Fermentation Market Competition Landscape
3.7. Epidemiology
4. Global Biopharmaceutical Fermentation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Biopharmaceutical Fermentation Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Upstream Process
5.1.1. Bioreactors/Fermentors
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Bioprocess Analyzers
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Process Monitoring System
5.1.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Culture & Media Preparation
5.1.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.1.5. Other Upstream Products
5.1.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3. Market Opportunity Analysis
5.2. Downstream Products
5.2.1. Filtration and Separation
5.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Chromatography
5.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Consumables and Accessories
5.2.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.2.4. Other Downstream Products
5.2.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.4.3. Market Opportunity Analysis
6. Global Biopharmaceutical Fermentation Market, By Application, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Antibiotics
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Recombinant Proteins
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Monoclonal Antibodies
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Probiotics
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Biopharmaceutical Fermentation Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Biopharmaceutical Industries
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Contract Research Organization
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Food Industry
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Academic Research Institutes
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Biopharmaceutical Fermentation Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Biopharmaceutical Fermentation Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Region, 2024 - 2030
9. North America Biopharmaceutical Fermentation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Upstream Process
9.1.1.1. Bioreactors/Fermentors
9.1.1.2. Bioprocess Analyzers
9.1.1.3. Process Monitoring System
9.1.1.4. Culture & Media Preparation
9.1.1.5. Other Upstream Products
9.1.2. Downstream Products
9.1.2.1. Filtration and Separation
9.1.2.2. Chromatography
9.1.2.3. Consumables and Accessories
9.1.2.4. Other Downstream Products
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Antibiotics
9.2.2. Recombinant Proteins
9.2.3. Monoclonal Antibodies
9.2.4. Probiotics
9.2.5. Others
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Biopharmaceutical Industries
9.3.2. Contract Research Organization
9.3.3. Food Industry
9.3.4. Academic Research Institutes
9.3.5. Other End-users
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Biopharmaceutical Fermentation Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2024 - 2030
9.6. North America Biopharmaceutical Fermentation Market Dynamics Trends
10. Europe Biopharmaceutical Fermentation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Upstream Process
10.1.1.1. Bioreactors/Fermentors
10.1.1.2. Bioprocess Analyzers
10.1.1.3. Process Monitoring System
10.1.1.4. Culture & Media Preparation
10.1.1.5. Other Upstream Products
10.1.2. Downstream Products
10.1.2.1. Filtration and Separation
10.1.2.2. Chromatography
10.1.2.3. Consumables and Accessories
10.1.2.4. Other Downstream Products
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Antibiotics
10.2.2. Recombinant Proteins
10.2.3. Monoclonal Antibodies
10.2.4. Probiotics
10.2.5. Others
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Biopharmaceutical Industries
10.3.2. Contract Research Organization
10.3.3. Food Industry
10.3.4. Academic Research Institutes
10.3.5. Other End-users
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Biopharmaceutical Fermentation Market - Opportunity Analysis Index, By Product Type, By Application, By End User and Country, 2024 - 2030
10.6. Europe Biopharmaceutical Fermentation Market Dynamics Trends
11. Asia-Pacific Biopharmaceutical Fermentation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Upstream Process
11.1.1.1. Bioreactors/Fermentors
11.1.1.2. Bioprocess Analyzers
11.1.1.3. Process Monitoring System
11.1.1.4. Culture & Media Preparation
11.1.1.5. Other Upstream Products
11.1.2. Downstream Products
11.1.2.1. Filtration and Separation
11.1.2.2. Chromatography
11.1.2.3. Consumables and Accessories
11.1.2.4. Other Downstream Products
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Antibiotics
11.2.2. Recombinant Proteins
11.2.3. Monoclonal Antibodies
11.2.4. Probiotics
11.2.5. Others
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Biopharmaceutical Industries
11.3.2. Contract Research Organization
11.3.3. Food Industry
11.3.4. Academic Research Institutes
11.3.5. Other End-users
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Biopharmaceutical Fermentation Market - Opportunity Analysis Index, By Product Type, By Application, By End User and Country, 2024 - 2030
11.6. Asia-Pacific Biopharmaceutical Fermentation Market Dynamics Trends
12. Latin America Biopharmaceutical Fermentation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Upstream Process
12.1.1.1. Bioreactors/Fermentors
12.1.1.2. Bioprocess Analyzers
12.1.1.3. Process Monitoring System
12.1.1.4. Culture & Media Preparation
12.1.1.5. Other Upstream Products
12.1.2. Downstream Products
12.1.2.1. Filtration and Separation
12.1.2.2. Chromatography
12.1.2.3. Consumables and Accessories
12.1.2.4. Other Downstream Products
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Antibiotics
12.2.2. Recombinant Proteins
12.2.3. Monoclonal Antibodies
12.2.4. Probiotics
12.2.5. Others
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Biopharmaceutical Industries
12.3.2. Contract Research Organization
12.3.3. Food Industry
12.3.4. Academic Research Institutes
12.3.5. Other End-users
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Biopharmaceutical Fermentation Market - Opportunity Analysis Index, By Product Type, By Application, By End User and Country, 2024 - 2030
12.6. Latin America Biopharmaceutical Fermentation Market Dynamics Trends
13. Middle East and Africa Biopharmaceutical Fermentation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
13.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Upstream Process
13.1.1.1. Bioreactors/Fermentors
13.1.1.2. Bioprocess Analyzers
13.1.1.3. Process Monitoring System
13.1.1.4. Culture & Media Preparation
13.1.1.5. Other Upstream Products
13.1.2. Downstream Products
13.1.2.1. Filtration and Separation
13.1.2.2. Chromatography
13.1.2.3. Consumables and Accessories
13.1.2.4. Other Downstream Products
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Antibiotics
13.2.2. Recombinant Proteins
13.2.3. Monoclonal Antibodies
13.2.4. Probiotics
13.2.5. Others
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Biopharmaceutical Industries
13.3.2. Contract Research Organization
13.3.3. Food Industry
13.3.4. Academic Research Institutes
13.3.5. Other End-users
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Biopharmaceutical Fermentation Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2024 - 2030
13.6. MEA Biopharmaceutical Fermentation Market Dynamics Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. GE Healthcare
14.2.2. Thermo Fisher Scientific Inc.
14.2.3. Danaher Corporation
14.2.4. Sartorius Stedim Biotech
14.2.5. Merck KGaA
14.2.6. Eppendorf AG
14.2.7. F. Hoffmann-La Roche Ltd.
14.2.8. Nova Biomedicals
14.2.9. Lonza
14.2.10. Becton
14.2.11. Dickinson and Company.
15. Research Methodology
16. Key Assumptions and Acronyms
  • GE Healthcare
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Sartorius Stedim Biotech
  • Merck KGaA
  • Eppendorf AG
  • Hoffmann-La Roche Ltd.
  • Nova Biomedicals
  • Lonza
  • Becton
  • Dickinson and Company.

Adjacent Markets